Literature DB >> 2596597

Regulation of ketone body flux in septic patients.

M Beylot1, M Guiraud, G Grau, P Bouletreau.   

Abstract

To assess the effect of sepsis on ketone body (KB) kinetics in humans, we measured in normal and septic subjects KB appearance rate (Ra) before (initial state) and during a rise of free fatty acids (FFA) level (intravenous infusion of a triglycerides emulsion). We studied normal subjects in postabsorptive state and septic patients when receiving an hypocaloric intravenous infusion of glucose and amino acids or 12 h after its interruption. When receiving glucose and amino acids infusion, septic patients had higher glucose and insulin levels than normal subjects, and despite lower FFA concentrations (255 +/- 44 vs. 480 +/- 51 mumol/l, P less than 0.05) comparable initial KB Ra (2.50 +/- 0.10 vs. 2.48 +/- 0.30 mumol.kg-1.min-1). Triglyceride infusion increased FFA to comparable values (septic 780 +/- 130, normal 730 +/- 45 mumol/l), but KB Ra rose in septic patients only to 3.7 +/- 1.1 instead of 7.7 +/- 1.1 mumol.kg-1.min-1 as in normal subjects (P less than 0.05). Somatostatin infusion decreased the hyperinsulinemia of septic patients but did not restore a normal ketogenesis. After interruption of nutriment infusion, septic patients had normal FFA levels and only mild hyperglycemia and hyperinsulinemia. Their initial KB Ra was not modified. However, their response of KB Ra (increase to 6.27 +/- 2.0 mumol.kg-1.min-1) to raised FFA levels (842 +/- 170 mumol/l) was comparable to the response of normal subjects. In conclusion, although septic patients receiving an hypocaloric parenteral nutrition had a depressed ketogenesis they were able to restore a normal ketogenic capacity after a short-time caloric deprivation. Glucose and/or insulin appears to have a major role in this modulation of hepatic ketogenesis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2596597     DOI: 10.1152/ajpendo.1989.257.5.E665

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

Review 1.  Lipid testing in infectious diseases: possible role in diagnosis and prognosis.

Authors:  Sebastian Filippas-Ntekouan; Evangelos Liberopoulos; Moses Elisaf
Journal:  Infection       Date:  2017-05-08       Impact factor: 3.553

2.  Influence of Glycemic Control on Endogenous Circulating Ketone Concentrations in Adults Following Traumatic Brain Injury.

Authors:  Stephanie M Wolahan; Mayumi L Prins; David L McArthur; Courtney R Real; David A Hovda; Neil A Martin; Paul M Vespa; Thomas C Glenn
Journal:  Neurocrit Care       Date:  2017-04       Impact factor: 3.210

Review 3.  When a calorie isn't just a calorie: a revised look at nutrition in critically ill patients with sepsis and acute kidney injury.

Authors:  Mridula Nadamuni; Andrea H Venable; Sarah C Huen
Journal:  Curr Opin Nephrol Hypertens       Date:  2022-06-10       Impact factor: 3.416

4.  Oxidation of D(-)3-hydroxybutyrate administered to rats with extensive burns.

Authors:  Y Mizobata; A Hiraide; M Katayama; H Sugimoto; T Yoshioka; T Sugimoto
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 5.  Metabolism as Disease Tolerance: Implications for Sepsis-Associated Acute Kidney Injury.

Authors:  Sarah C Huen
Journal:  Nephron       Date:  2021-06-23       Impact factor: 3.457

6.  LPS decreases fatty acid oxidation and nuclear hormone receptors in the kidney.

Authors:  Kenneth R Feingold; Yuwei Wang; Arthur Moser; Judy K Shigenaga; Carl Grunfeld
Journal:  J Lipid Res       Date:  2008-06-23       Impact factor: 5.922

7.  N-3 Polyunsaturated Fatty Acids Improve Liver Lipid Oxidation-Related Enzyme Levels and Increased the Peroxisome Proliferator-Activated Receptor α Expression Level in Mice Subjected to Hemorrhagic Shock/Resuscitation.

Authors:  Li Zhang; Feng Tian; Xuejin Gao; Xinying Wang; Chao Wu; Ning Li; Jieshou Li
Journal:  Nutrients       Date:  2016-04-22       Impact factor: 5.717

8.  Impact of tight glucose control on circulating 3-hydroxybutyrate in critically ill patients.

Authors:  Jan Gunst; Astrid De Bruyn; Michael P Casaer; Sarah Vander Perre; Lies Langouche; Greet Van den Berghe
Journal:  Crit Care       Date:  2021-10-25       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.